Allergan Makes Yet Another Acquisition

Acquisitive pharmaceutical major Allergan (NYSE: AGN) is at it again: The drugmaker has opened its wallet for another in its series of asset buys. This time, it is purchasing privately held Chase Pharmaceuticals, a clinical-stage biopharma that is developing drugs to treat neurodegenerative afflictions such as Alzheimer’s disease. …read more

Read more here: Allergan Makes Yet Another Acquisition

Category: AGN

Leave a Reply

%d bloggers like this: